Open Government Portal

Found 10 records similar to Directive on Physical Security Requirements for Controlled Substances and Drugs Containing Cannabis

Federal

The purpose of this document is to provide guidance to holders of a licence under the Cannabis Act (hereafter referred to as licence holders) on the application of Part 4: Physical Security Measures of the Cannabis Regulations. It is designed to help licence holders understand the physical security requirements for conducting authorized activities with cannabis.

Last Updated: Jun. 27, 2022
Date Published: Jul. 6, 2021
Organization: Health Canada
Formats: HTML
Keywords:  guide for cannabis, physical security measures, cannabis regulations Part-4, requirements under cannabis-regulations
Federal

Pursuant to section 56 of the CDSA and subject to the terms and conditions set out herein, applicants for a producer’s licence are exempted from the requirement in paragraph 33(1)(h) to provide a detailed description of security measures determined in accordance with the Security Directive in respect of the storage of cannabis and from the application of paragraph 33(1)(h) of the ACMPR in respect of the proposed security measures that apply in respect of the areas where cannabis plants are cultivated, propagated, harvested or trimmed and to the areas where cannabis seeds are present or stored.

Last Updated: Jun. 27, 2022
Date Published: Jan. 30, 2018
Organization: Health Canada
Formats: HTML
Keywords:  Section-56 Class Exemption, access-to-cannabis for medical-purposes, cannabis regulations, physical security requirements, applicants for licence-to-produce-cannabis, producer’s licence, exempted from requirements, paragraph 33(1)(h), description of security-measures
Federal

The purpose of this document is to inform stakeholders about the regulatory framework for health products containing cannabis or for use with cannabis that are approved under the Food and Drugs Act. This framework includes requirements for licensed activities, rules that apply to the health products themselves, and obligations for certain healthcare professionals.

Last Updated: Jun. 28, 2022
Date Published: Nov. 19, 2021
Organization: Health Canada
Formats: HTML
Keywords:  cannabis, regulatory framework, for use, cannabis allowed, approved under the Food and Drugs Act, framework includes requirements for licensed activities, obligations for certain healthcare professionals.
Federal

Health Canada is issuing this notice to clinical trial sponsors to clarify key obligations under the Food and Drug Regulations (FDR) for various types of cannabis-based clinical research.

Last Updated: Jun. 1, 2021
Date Published: Feb. 5, 2021
Organization: Health Canada
Formats: HTML
Keywords:  notice to stakeholders, clarification of requirements, Food and Drug Regulations, clinical trial, clinical research, cannabis
Federal

Health Canada's interpretation of controlled substances prescribing activities pharmacists can perform under the Controlled Drugs and Substances Act.

Last Updated: Mar. 25, 2021
Date Published: Apr. 21, 2020
Organization: Health Canada
Formats: HTML
Keywords:  56(1) class exemption, Controlled Drugs and Substances Act, CDSA, pharmacists, prescriptions, controlled substance, prescribing activities, adjusting formulation, doses
Federal

Between 2018 and 2020, Health Canada has issued a number of exemptions to the Controlled Drugs and Substances Act. Some of the exemptions have been issued to maintain Canadians' access to controlled substances during the COVID-19 pandemic.

Last Updated: Jan. 6, 2021
Date Published: Jul. 16, 2020
Organization: Health Canada
Formats: HTML
Keywords:  COVID-19, pandemic, controlled substances, Controlled Drugs and Substances Act, relevant exemptions
Federal

People use substances, such as controlled and illegal drugs, cannabis, tobacco/nicotine and alcohol for different reasons, including: medical purposes, personal enjoyment, religious or ceremonial purposes and to cope with stress, trauma or pain.

Last Updated: Feb. 1, 2023
Date Published: Jun. 2, 2022
Organization: Health Canada
Formats: HTML
Keywords:  substance use, substance use spectrum, controlled-and-illegal drugs, cannabis, tobacco/nicotine, alcohol, for medical purposes, personal enjoyment, religious-or-ceremonial purposes
Federal

On August 24, 2016, Health Canada issued a Section 56 Class Exemption under the Controlled Drugs and Substances Act to enable registered persons under the Access to Cannabis for Medical Purposes Regulations (ACMPR), and individuals responsible for them, to access testing services for dried or fresh marijuana or cannabis oil produced for their own medical purposes.

Last Updated: Jun. 27, 2022
Date Published: Jul. 11, 2017
Organization: Health Canada
Formats: HTML
Keywords:  Licensed dealer testing, cannabis produced by-individuals, Section 56 Class Exemption, Controlled Drugs-and-Substances Act, registered persons, Access-to-Cannabis for Medical-Purposes-Regulations, ACMPR, testing-services for dried-or-fresh-marijuana, cannabis-oil produced for-medical-purposes
Federal

Health Canada is issuing this Notice to clinical trial sponsors to clarify the approach to various types of clinical research with cannabis.

Last Updated: Dec. 29, 2021
Date Published: Sep. 11, 2021
Organization: Health Canada
Formats: HTML
Keywords:  Food and Drug Regulations, clarification of requirements, clinical trial sponsors, clinical-research with cannabis, cannabis clinical research
Federal

Health Canada is issuing this Notice to clinical trial sponsors to clarify the approach to various types of clinical research with cannabis.

Last Updated: Dec. 29, 2021
Date Published: Sep. 11, 2021
Organization: Health Canada
Formats: HTML
Keywords:  Food and Drug Regulations, clarification of requirements, clinical trial sponsors, clinical-research with cannabis, cannabis clinical research
Date modified: